Navigation Links
Federal grant of $275,000 funds study of young adult attitudes toward flavored tobacco
Date:9/17/2013

Dr. Kymberle Sterling, assistant professor in the School of Public Health at Georgia State University, has received a two-year, $275,000 grant from the National Cancer Institute to study how young adult smokers perceive the risk of smoking flavored little cigars and cigarillos (LCCs), which the Food and Drug Administration (FDA) does not regulate.

The health risks associated with smoking flavored LCCs are very similar to those from cigarettes. They cause nicotine dependence and cancer.

The grant will allow Sterling, with investigators at the University of Hawaii-Manoa Cancer Center and the University of Maryland College Park School of Public Health, to develop a prognostic tool that identifies LCC risk perceptions and predicts susceptibility to smoke LCCs among young adult cigarette smokers.

Use of flavored LCCs is growing at an alarming rate among young adult cigarette smokers, especially those from ethnic minority groups. Preliminary data show young adult smokers enjoy the taste and smell of LCCs, consider smoking LCCs with peers as "cool" and feel they can quit LCCs anytime. Early indicators suggest these smokers believe LCCs are less harmful than cigarettes.

"Dr. Sterling's research, which adds to a growing body of tobacco expertise at Georgia State, will help inform how we respond to one of the latest threats in the battle against tobacco," noted School of Public Health dean and lead author of the "Tobacco Atlas," Michael P. Eriksen. "It is expected to help scientists and policy makers understand the ways in which young adult cigarette smokers think about and respond to risks related to flavored LCCs."

The 2010 Family Smoking Prevention and Tobacco Control Act authorized the FDA to regulate the manufacture, distribution and marketing of flavored cigarettes, with the exception of menthol cigarettes, but did not grant regulatory authority over flavored little cigars and cigarillos (LCCs). LCCs are tobacco products inhaled like cigarettes and similar in size, shape, filtering and tobacco pH.

The tobacco control community knows very little about how young adult cigarette smokers form risk perceptions of LCCs. Researchers believe understanding young adult smokers' attitudes is vital to effective regulatory policy as well as prevention methods.


'/>"/>

Contact: Frances Marine
francesmarine@gsu.edu
404-413-1504
Georgia State University
Source:Eurekalert

Related medicine news :

1. DrugRisk Update: Byetta Lawsuits Headed to Special Federal Court
2. DePuy ASR Hip Replacement Lawsuit Trial: Jury Selection in First Federal Trial of DePuy ASR Hip Recall Lawsuit to Begin on September 24th, Wright & Schulte LLC Reports
3. Pradaxa Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Pradaxa Bleeding Litigation
4. Biomet Hip Replacement News: Federal Multidistrict Litigation for Biomet Hip Lawsuits to Hold Status Conference, Bernstein Liebhard LLP Reports
5. Actos Lawsuit News: Bernstein Liebhard LLP Notes Scheduling of Next Status Conference in Federal Actos Bladder Cancer Litigation
6. Transvaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Upcoming Joint Conference for Federal Vaginal Mesh Lawsuits
7. DePuy Pinnacle Lawsuits: Bernstein Liebhard LLP Reports on Latest Developments in Federal Pinnacle Hip Lawsuits
8. Pradaxa Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Issuance of New Case Management Order in Federal Pradaxa Bleeding Litigation
9. Biomet Hip Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Issuance of New Case Management Order in Federal Biomet Hip Replacement Litigation
10. DrugRisk Update: Januvia Lawsuits Alleging Cancer Headed to Federal Court
11. DrugNews: Federal Court Moves Growing Mirena Lawsuits Forward
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... Ongoing news of the ravages of traumatic brain ... conduct a survey that takes a closer look at cases of TBI being managed ... causes of TBI among the aging population, and identifies the challenges associated with their ...
(Date:2/10/2016)... MI (PRWEB) , ... February 10, 2016 , ... ... Apifiny® across their network of laboratory service centers across the country. Launched ... to aid clinicians in the detection of prostate cancer. Apifiny order volume exceeded 3,000 ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... ... announced that it has been awarded the prestigious Distinguished Emerald Club of the ... program conducted by BoardRoom magazine, one of the most respected trade publications serving ...
(Date:2/10/2016)... ... February 10, 2016 , ... Workrite Ergonomics, who is celebrating ... evolved from humble beginnings to being an internationally recognized leader in their industry. , ... today”, said Charlie Lawrence, President of Workrite. “Workrite recognized the importance of good ...
(Date:2/10/2016)... ... February 09, 2016 , ... ... Face and Body Specialists are delighted to welcome a new addition to their ... Face and Body Specialists as a nurse practitioner performing cosmetic procedures ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... and SAN DIEGO , ... Inc., a global leader in viral gene therapy manufacturing, ... treatments for congestive heart failure and other chronic diseases, ... a scalable manufacturing process and produce cGMP-grade RT-100 (Ad5.hAC6) ... --> --> ...
(Date:2/10/2016)... 2016 Immune Pharmaceuticals Inc. (NASDAQ: IMNP ... it has filed a patent application directed to the ... --> --> The new ... Ceplene (histamine dihydrochloride) in combination with immune checkpoint inhibitors. ... efficacy of Ceplene and IL-2 therapy in patients with ...
(Date:2/10/2016)... Feb. 10, 2016  Oxis International Inc. (OTC/QB: OXIS) ... was described as a "clinical trial triumph" after one ... into complete cancer remission. Daniel Vallera ... Masonic Cancer Center. --> Daniel Vallera ... Masonic Cancer Center. --> An article ...
Breaking Medicine Technology: